Skip to main content

Table 4 Number of persons with prescription by AD class and sociodemographics

From: Antidepressant prescription practice and related factors in Switzerland: a cross-sectional analysis of health claims data

 

SSRIs

n (%)

TCA

n (%)

MAOIs

n (%)

Others

n (%)

Total

55,236 (52.3a)

13,708 (13.0a)

255 (0.2a)

53,971 (51.1a)

Gender

 Female

37,864 (68.5)

9411 (68.7)

145 (43.1)

35,222 (65.3)

 Male

17,372 (31.5)

4297 (31.3)

110 (56.9)

18,749 (34.7)

Age group

 0–14

103 (0.2)

5 (0.1)

0 (0.0)

78 (0.1)

 15–24

2284 (4.1)

309 (2.3)

5 (2.0)

1875 (3.5)

 25–34

4469 (8.1)

738 (5.4)

20 (7.8)

4033 (7.5)

 35–44

7205 (13.0)

1358 (9.9)

41 (16.1)

6701 (12.4)

 45–54

9751 (17.7)

2371 (17.3)

51 (20.0)

10,026 (18.6)

 55–64

9357 (16.9)

2842 (20.7)

43 (16.9)

9043 (17.9)

 65–74

8216 (14.9)

2672 (19.5)

52 (20.4)

7958 (14.7)

 75–84

8044 (14.6)

2264 (16.5)

25 (9.8)

8125 (15.1)

  ≥ 85

5807 (10.5)

1149 (8.4)

18 (7.1)

5522 (10.2)

Area of residence

 Urban area

44,086 (79.8)

10,776 (78.6)

205 (80.4)

42,790 (79.3)

 Rural area

11,150 (20.2)

2932 (21.4)

50 (19.6)

11,181 (20.7)

  1. SSRIs selective serotonin reuptake inhibitors, TCA tricyclic antidepressants, MAOIs monoamine oxidase inhibitors; apercentages are related to the subsample with AD prescriptions (n = 105,663); all other percentages as related to the total amount per AD class